Skip to main content
TipRanks
Go Ultimate75% OFF

David J. Boyle Insider Profile

4 Followers

David J. Boyle, CEO at Sarepta Therapeutics, holds 70.28K shares in Sarepta Therapeutics (Ticker: SRPT), holds 18.93K shares in XOMA Royalty Corporation (Ticker: XOMA). Most recently, David J. Boyle Bought ― shares of Sarepta Therapeutics on Aug 27, 2010 for an estimated value of $10.60K.

David J. Boyle's Trading History

SRPT
Sarepta Therapeutics
Aug 27, 2010CEOInformative Buy10.60K$1.13M
XOMA
XOMA Royalty Corporation
―――$760.58K

You May Also Like

David J. Boyle insider profile FAQ

What is the percentage of profitable transactions made by David J. Boyle?
The percentage of profitable transactions made by David J. Boyle is 50%.
What is the average return per transaction made by David J. Boyle?
The average return per transaction made by David J. Boyle is 29.80%.
What stocks does David J. Boyle hold?
David J. Boyle holds: SRPT, XOMA stocks.
What was David J. Boyle’s latest transaction?
David J. Boyle’s latest transaction was an Informative Buy of $10.60K.
What was David J. Boyle's most profitable transaction?
David J. Boyle’s most profitable transaction was an Informative Buy of SRPT stock on March 13, 2009. The return on the trade was 104.60%.
What is David J. Boyle's role in Sarepta Therapeutics?
David J. Boyle's role in Sarepta Therapeutics is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.